Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease

被引：5
|
作者：
Katsiki, Niki [2 ]
Elisaf, Moses [1 ]
机构：
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Propedeut Dept Internal Med 1, GR-54006 Thessaloniki, Greece
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2011年 / 27卷 / 08期
关键词：
Cardiovascular risk; Chronic kidney disease; Metabolic syndrome; Multifactorial treatment; Renal function; Statin; Uric acid; GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; URIC-ACID LEVELS; PERIPHERAL ARTERIAL-DISEASE; TYPE-2; DIABETES-MELLITUS; ALL-CAUSE MORTALITY; GREEK ATORVASTATIN; SUBGROUP ANALYSIS; EVALUATION GREACE; VASCULAR-DISEASE;
D O I：
10.1185/03007995.2011.596410
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1669 / 1672
页数：4
相关论文
共 50 条
  • [1] Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study
    Athyros, Vassilios G.
    Karagiannis, Asterios
    Ganotakis, Emmanouel S.
    Paletas, Konstantinos
    Nicolaou, Vassilios
    Bacharoudis, George
    Tziomalos, Konstantinos
    Alexandrides, Theodore
    Liberopoulos, Evangelos N.
    Mikhailidis, Dimitri P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (08) : 1659 - 1668
  • [2] Statins in Chronic Kidney Disease: Cardiovascular Risk and Kidney Function
    Deedwania, Prakash C.
    POSTGRADUATE MEDICINE, 2014, 126 (01) : 29 - 36
  • [3] Frequency of Cardiovascular Risk Factors and Metabolic Syndrome in Patients with Chronic Kidney Disease
    Sagun, Gul
    Kantarci, Gulcin
    Mesci, Banu
    Gungor, Sinem
    Turkoglu, Funda
    Yorulmaz, Elif
    Oguz, Aytekin
    CLINICAL MEDICINE & RESEARCH, 2010, 8 (3-4) : 135 - 141
  • [4] The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
    Rysz, Jacek
    Gluba-Brzozka, Anna
    Rysz-Gorzynska, Magdalena
    Franczyk, Beata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)
  • [5] Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease - ready for prime time?
    Korantzopoulos, Panagiotis
    Elisaf, Moses
    Milionis, Haralampos J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (10) : 2768 - 2774
  • [6] Metabolic syndrome and chronic kidney disease as risk factors of osteoporosis
    Shin, Jung-ho
    Kim, Su Hyun
    Yu, Suk-Hee
    CLINICAL NEPHROLOGY, 2014, 81 (01) : 1 - 8
  • [7] Metabolic Syndrome in Patients with Chronic Kidney Disease
    Kaykhaei, Mahmoud Ali
    Shahraki, Elham
    Motamedi, Maryam
    Ansari-Moghaddam, Alireza
    Mohammadi, Mahdi
    Fatideh, Tahereh Mohammadi
    CLINICAL & TRANSLATIONAL METABOLISM, 2024, 22 (01)
  • [8] Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment?
    Bazyluk, Angelika
    Malyszko, Jolanta
    Zbroch, Edyta
    POSTGRADUATE MEDICINE, 2018, 130 (05) : 461 - 469
  • [9] Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk
    Piko, Nejc
    Bevc, Sebastjan
    Ekart, Robert
    Petreski, Tadej
    Vodosek Hojs, Nina
    Hojs, Radovan
    WORLD JOURNAL OF DIABETES, 2021, 12 (07) : 975 - 996
  • [10] Evolution of cardiovascular risk with advancing stages of chronic kidney disease
    Rozentryt, Piotr
    Polonski, Lech
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 6 (03) : 279 - 288
12345